Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

AGC to Expand Biopharmaceutical Production in US

Filed Under: Industry, Pharma Tagged With: , , , , , ,

AGC Inc. (TYO:5201), formerly known as Asahi Glass Co. Ltd., is gearing up to expand its biopharmaceuticals production in the…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

AGC in Race to Bolster CDMO Operations Across US, Europe and Japan
AGC in Race to Bolster CDMO Operations Across US, Europe and…
Raw Material Shortages Create Difficulties in Biopharma Production
Raw Material Shortages Create Difficulties in Biopharma…
Asahi Kasei Medical to Enter Pharmaceutical CDMO Business
Asahi Kasei Medical to Enter Pharmaceutical CDMO Business
Sekisui Chemical to Build New Biopharmaceutical Plant in UK
Sekisui Chemical to Build New Biopharmaceutical Plant in UK
Interview: Cytiva CEO Emmanuel Ligner Discusses Booming Business, Future Plans
Interview: Cytiva CEO Emmanuel Ligner Discusses Booming…
AGC Aims for Three Strategic Businesses to Make up 40% of Operating Profit in 2025
AGC Aims for Three Strategic Businesses to Make up 40% of…